Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00328939 | ARIXTRA Local Study For Registration In China. | PHASE3 | COMPLETED | 240 | — | — | May 1, 2004 | - | Jun 4, 2012 | 7 | China |
| Name | Type | Description |
|---|---|---|
| ARIXTRA infusion | DRUG | - |
| Enoxaparine infusion | DRUG | - |
Inclusion criteria: * Patients undergoing either an elective major hip or knee replacement or revision. * Signed written informed consent. Men or women of non-child bearing potential(i.e., post menopausal or with hysterectomy of bilateral tubule ligation) or women of childbearing potential without ...